Acrux Ltd has released a press release.
New intellectual property application for onychomycosis
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Acrux
- Axiron Net Sales, Quarter to September 2016
- Acrux announces 2016 financial results
- Acrux announces court ruling on Axiron patent families
- Axiron Net Sales, quarter to June 2016
- Acrux generic strategy and Axiron patent litigation update
Later from Acrux
- IPR Petition Filed Against Key Jublia Patent
- European approvals and milestone payments for Lenzetto
- S&P DJ Indices Announces March Quarterly Review
- Axiron Net Sales, Quarter to December2016
- Appendix 4D and Half Year Report to 31 December 2016
Follow Acrux into a list and get an email when it puts out news.
Follow Acrux